29
35.
Politis, M.
et al. Parkinson’s disease symptoms: the patient's perspective.
Mov. Disord. 25, 1646–51 (2010).
36.
Visser, M.
et al. A comprehensive model of health-related quality of life in Parkinson’s disease.
J. Neurol. 255, 1580–7 (2008).
37.
Rahman, S., Griffin, H. J., Quinn, N. P. & Jahanshahi, M. Quality of life in Parkinson’s disease: the relative importance of the symptoms.
Mov Disord
23, 1428–34 (2008).
38.
Goetz, C. G.
et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.
Mov. Disord.
19, 1020–8 (2004).
39.
Evans, J. R.
et al. The natural history of treated Parkinson’s disease in an incident, community based cohort.
J. Neurol. Neurosurg. Psychiatry 82,
1112–8 (2011).
40.
Sato, K. et al. Prognosis of Parkinson’s disease: time to stage III, IV, V, and to motor fluctuations. Mov. Disord. 21, 1384–95 (2006).
41.
Fall, P. A., Saleh, A., Fredrickson, M., Olsson, J. E. & Granérus, A. K. Survival time, mortality, and cause of death in elderly patients with
Parkinson’s disease: A 9-year follow-up. Mov. Disord. 18, 1312–1316 (2003).
42.
Fernandez, H. H. & Lapane, K. L. Predictors of mortality among nursing home residents with a diagnosis of Parkinson’s disease.
Med. Sci. Monit. 8,
CR241–R246 (2002).
43.
Hely, M. a, Reid, W. G. J., Adena, M. a, Halliday, G. M. & Morris, J. G. L. The Sydney multicenter study of Parkinson’s disease: the inevitability of
dementia at 20 years.
Mov. Disord. 23, 837–44 (2008).
44.
Schrag, A. & Schott, J. M. Epidemiological , clinical , and genetic characteristics of early-onset parkinsonism.
5, (2006).
45.
Abendroth, M., Lutz, B. J. & Young, M. E. Family caregivers’ decision process to institutionalize persons with Parkinson's disease: a
grounded theory
study. Int. J. Nurs. Stud. 49, 445–54 (2012).
46.
Goetz, C. G. & Stebbins, G. T. Risk factors for nursing home placement in advanced Parkinson’s disease. Neurology 43, 2227–2229 (1993).
47.
Hely, M. a et al. The sydney multicentre study of Parkinson’s disease: progression and mortality at 10 years. J. Neurol. Neurosurg. Psychiatry 67,
300–307 (1999).
48.
Hely, M. a., Morris, J. G. L., Reid, W. G. J. & Trafficante, R. Sydney Multicenter Study of Parkinson’s disease: Non-L-dopa-responsive problems
dominate at 15 years. Mov. Disord. 20, 190–199 (2005).
49.
Willis, a W., Schootman, M. & Evanoff, B. a. Neurologist care in Parkinson disease. 851–858 (2011). doi:10.1212/WNL.0b013e31822c9123
50.
Steendam-oldekamp, T. E., Rutgers, a W. F. W. & Buskens, E. Kortdurende gespecialiseerde revalidatie van Parkinson-patiënten stelt
verpleeghuisopname uit. 156, 0–5 (2012).
51.
Keus, S.
et al. European Physiotherapy Guideline for Parkinson’s Disease Developed with twenty European professional associations.
52.
van der Marck, M. a
et al. Effectiveness of multidisciplinary care for Parkinson’s disease: a randomized, controlled trial.
Mov. Disord. 28, 605–11
(2013).
53.
Morris, M. Movement disorders in people with Parkinson disease: a model for physical therapy. Phys. Ther. 80, 578–597 (2000).
54.
Meek, C. E. Improving the clinical effectiveness of physiotherapy in Parkinson¿s disease. PQDT - UK Irel. (2012). at
2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&genre=dissertations+&+theses&sid=ProQ:ProQuest+Dissertations+&+Theses:+UK+&+Irel>
55.
van Nimwegen, M. et al. Physical inactivity in Parkinson’s disease. J. Neurol. 258, 2214–21 (2011).
56.
Ellis, T. et al. Factors associated with exercise behavior in people with Parkinson disease. Phys. Ther. 91, 1838–48 (2011).
57.
Nilsson, M. H., Drake, A.-M. & Hagell, P. Assessment of fall-related self-efficacy and activity avoidance in people with Parkinson’s disease. BMC
Geriatr. 10, 78 (2010).
58.
Manini, T. M. & Clark, B. C. Dynapenia and aging: an update. J. Gerontol. A. Biol. Sci. Med. Sci. 67, 28–40 (2012).
59.
Allen, N. E., Sherrington, C., Canning, C. G. & Fung, V. S. C. Reduced muscle power is associated with slower walking velocity and falls in people
with Parkinson’s disease. Parkinsonism Relat. Disord. 16, 261–4 (2010).
60.
Inkster, L. M., Eng, J. J., MacIntyre, D. L. & Stoessl, a J. Leg muscle strength is reduced in Parkinson’s disease and relates to the ability to rise from
a chair. Mov. Disord. 18, 157–62 (2003).
61.
Paul, S. S., Canning, C. G., Sherrington, C. & Fung, V. S. C. Reduced muscle strength is the major determinant of reduced leg muscle power in
Parkinson’s disease. Parkinsonism Relat. Disord. 18, 974–7 (2012).
62.
Schilling, B. K. et al. Impaired leg extensor strength in individuals with Parkinson disease and relatedness to functional mobility. Parkinsonism Relat.
Disord. 15, 776–80 (2009).
63.
Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, K. P. Effect of physical inactivity on major non- communicable diseases worldwide: an analysis of
burden of disease and life expectancy. Lancet 380, 219–229 (2012).
64.
Benecke, R., Rothwell, J., Dick, J., Day, B. & Marsden, C. Disturbance of Sequential Movements in Patients With Parkinsons-Disease. 110, 1987
(1987).
65.
Kamsma, Y. P. T., Brouwer, W. H. & Lakke, J. P. W. F. Training of compensational strategies for impaired gross motor skills in Parkinson’ disease.
Physiother. Theory Pract. 11, 209–229 (1995).
66.
Mak, M. K. Y., Yang, F. & Pai, Y.-C. Limb collapse, rather than instability, causes failure in sit-to-stand performance among patients with parkinson
disease. Phys. Ther. 91, 381–91 (2011).
67.
Pohar, S. L. & Allyson Jones, C. The burden of Parkinson disease (PD) and concomitant comorbidities. Arch. Gerontol. Geriatr. 49, 317–321 (2009).
68.
Nijkrake, M. & Keus, S. Evaluation of a Patient-Specific Index as an outcome measure for physiotherapy in Parkinson’s disease. Eur J Physi Rehabil
Med 45, 507–512 (2009).
69.
Broeder, S. et al. The effects of dual tasking on handwriting in patients with Parkinson’s disease. Neuroscience 263, 193–202 (2014).